Last €4.46 EUR
Change Today +0.067 / 1.53%
Volume 250.0
GNJC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 6:43 AM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

skystar bio-pharmaceutical (GNJC) Snapshot

Open
€4.55
Previous Close
€4.39
Day High
€4.55
Day Low
€4.46
52 Week High
03/24/14 - €5.21
52 Week Low
05/20/13 - €0.86
Market Cap
33.9M
Average Volume 10 Days
154.8
EPS TTM
--
Shares Outstanding
7.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SKYSTAR BIO-PHARMACEUTICAL (GNJC)

Related News

No related news articles were found.

skystar bio-pharmaceutical (GNJC) Related Businessweek News

No Related Businessweek News Found

skystar bio-pharmaceutical (GNJC) Details

Skystar Bio-Pharmaceutical Company, through its subsidiaries, engages in the research, development, production, marketing, and sale of veterinary healthcare and medical care products in the People’s Republic of China. It provides micro-organism products; veterinary medicines for poultry and livestock; feed additives; bio-pharmaceutical veterinary vaccines; and aquaculture medicines. The company sells its products through distributors, as well as directly to customers. Skystar Bio-Pharmaceutical Company is headquartered in Xi’an, the People’s Republic of China.

318 Employees
Last Reported Date: 03/31/14

skystar bio-pharmaceutical (GNJC) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $121.6K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $182.5K
Compensation as of Fiscal Year 2013.

skystar bio-pharmaceutical (GNJC) Key Developments

Skystar Bio-Pharmaceutical Company Announces Consolidated Earnings Results for the Year Ended December 31, 2013; Provides Revenue Guidance for the Year 2014

Skystar Bio-Pharmaceutical Company announced consolidated earnings results for the year ended December 31, 2013. Revenues totaled $42.5 million, a 26.5% increase compared to the $33.6 million in revenues reported for the full fiscal 2012 year. Net income increased 69.5% year over year to $10.5 million or $1.37 per fully diluted share, as compared to $6.2 million or $0.83 per fully diluted share in the year ago period. Income from operations was $13.012 million against $8.550 million a year ago. Income before provision for income taxes was $12.931 million against $8.380 million a year ago. Net cash used in operating activities was $5.423 million against net cash from operating activities of $6.546 million a year ago. Purchases of property, plant and equipment were $19,825 against $163.049 million a year ago. For the year 2014, the company expects revenue range is $46 million to $50 million with gross margin of roughly 50% for fiscal 2014.

Skystar Bio Pharmaceutical Company, 2013 Earnings Call, Apr 01, 2014

Skystar Bio Pharmaceutical Company, 2013 Earnings Call, Apr 01, 2014

Skystar Bio Pharmaceutical Company to Report Fiscal Year 2013 Results on Mar 31, 2014

Skystar Bio Pharmaceutical Company announced that they will report fiscal year 2013 results at 5:00 PM, China Standard Time on Mar 31, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNJC:GR €4.46 EUR +0.067

GNJC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Animal Husbandry Industry Co Ltd CNY12.75 CNY -0.18
Guangdong VTR Bio-Tech Co Ltd CNY44.72 CNY -1.11
Inner Mongolia Jinyu Group Ltd CNY26.27 CNY +0.04
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd CNY10.24 CNY -0.18
View Industry Companies
 

Industry Analysis

GNJC

Industry Average

Valuation GNJC Industry Range
Price/Earnings 4.6x
Price/Sales 1.1x
Price/Book 0.4x
Price/Cash Flow 4.5x
TEV/Sales 0.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SKYSTAR BIO-PHARMACEUTICAL, please visit www.skystarbio-pharmaceutical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.